ARTICLE | Company News
IBL Gesellschaft fuer Immunchemie und Immunbiologie mbH, Immuno-Biological Laboratories, Innogenetics sales and marketing update
January 1, 2007 8:00 AM UTC
INNX received exclusive worldwide rights to distribute Immuno-Biological's ELISA-based tests for identifying specific forms of the beta amyloid protein in Alzheimer's disease (AD). The deal excludes ...